Press Releases Keyword Search Year None202120202019201820172016201520142013 Jan 19, 2021 Seres Therapeutics to Present SER-109 Phase 3 Mechanistic Data at Keystone Symposium Jan 06, 2021 Seres Therapeutics to Present at 39th Annual J.P. Morgan Healthcare Conference Jan 06, 2021 Seres Therapeutics Publishes Positive SER-287 Phase 1b Ulcerative Colitis Study Results in Journal Gastroenterology Pagination First page « first Previous page ‹ previous Page 1 Current page 2
Jan 06, 2021 Seres Therapeutics Publishes Positive SER-287 Phase 1b Ulcerative Colitis Study Results in Journal Gastroenterology
